MicroRNA-mediated drug resistance in breast cancer
2011 · Clinical Epigenetics · 168 citations
https://doi.org/10.1007/s13148-011-0040-8
F
Frederick A. Beland
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
495
Papers
19.0K
Citations
70
h-index
320
i10-index
Frederick A. Beland is an academic researcher from National Center for Toxicological Research. The author has contributed to research in topics: Carcinogens and Genotoxicity Assessment & DNA Repair Mechanisms & Liver Disease Diagnosis and Treatment. The author has an h-index of 70, co-authored 421 publications.
ORCID: 0000-0002-2113-6260Papers by this author
worksIARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans
2015 · Environmental Health Perspectives · 131 citations
https://doi.org/10.1289/ehp.1409149
Carcinogenicity of acrylamide in B6C3F1 mice and F344/N rats from a 2-year drinking water exposure
2012 · Food and Chemical Toxicology · 129 citations
https://doi.org/10.1016/j.fct.2012.09.017
Rapid isolation, hydrolysis and chromatography of formaldehyde-modified DNA
1984 · Journal of Chromatography B Biomedical Sciences and Applications · 100 citations
https://doi.org/10.1016/0378-4347(84)80202-9
Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma
2020 · Toxicology Reports · 30 citations
https://doi.org/10.1016/j.toxrep.2020.12.022
Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice
2016 · BMC Genomics · 26 citations
https://doi.org/10.1186/s12864-016-2617-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat